相关实验视频

Updated: Sep 9, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

在复发性或耐火性多发性骨髓瘤中利用定量系统药理建模来优化埃拉纳他马布治疗方案

Kamrine E Poels¹, Mohamed Elmeliegy², Jennifer Hibma¹

¹Pharmacometrics & Systems Pharmacology, Pfizer Research & Development, San Diego, CA, USA.

NPJ systems biology and applications

|September 1, 2025

概括

一种双特异性抗体 (BsAb) Elranatamab通过连接T细胞和骨髓瘤细胞有效治疗多发性骨髓瘤. 一个新的模型支持每周76mg的剂量,即使具有高可溶性BCMA水平,优化治疗.

科学领域:

免疫学
药理学
癌症学

背景情况:

埃尔拉纳塔马布是一种双特异性抗体 (BsAb),已被批准用于复发性/ 耐药性多发性骨髓瘤.
它通过T细胞 (通过CD3) 和B细胞成熟抗原 (BCMA) 在髓瘤细胞之间形成免疫突触来起作用.
可溶性BCMA (sBCMA) 是一种与疾病负担相关的生物标志物,可能会影响elranatamab的暴露和疗效.

研究的目的:

开发一个定量系统药理学 (QSP) 模型,用于埃拉纳塔马布的作用机制和多发性骨髓瘤的动态.
探索模型的不确定性和患者间的可变性,以告知剂量反应关系.
评估基线sBCMA水平对elranatamab剂量和治疗方案的影响.

主要方法:

使用临床数据集开发和校准了一种定量系统药理 (QSP) 模型.
进行模拟以调查模型不确定性和患者间的可变性.
该模型用于评估剂量反应关系和sBCMA对疗效的影响.

主要成果:

模型模拟确定每周76毫克为最佳的埃拉拉纳塔马布治疗方案,即使在高sBCMA患者中也是有效的.
虚拟反应者的剂量反应曲线向左移动表明,使用较少的剂量可以保持疗效.
该模型成功地捕捉了elranatamab的作用机制和疾病动态.

结论:

机理模型支持以模型为基础的药物开发框架内对elranatamab的剂量和治疗方案的证明.
这些发现支持目前的剂量方案,并建议优化,更少的剂量策略.
这种方法证明了QSP模型在优化多发性骨髓瘤双特异性抗体治疗中的有用性.

更多相关视频

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

相关概念视频

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...